Viking Therapeutics, Inc. (NASDAQ:VKTX) Q2 2024 Earnings Call Transcript

Viking Therapeutics, Inc. (NASDAQ:VKTX) Q2 2024 Earnings Call Transcript July 24, 2024

Viking Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.20156, expectations were $-0.26.

Operator: Welcome to the Viking Therapeutics Second Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Following management’s prepared remarks, we will hold a Q&A session. [Operator Instructions] As a reminder, this conference call is being...